Theravance Biopharma, Inc. Increase (Decrease) in Income Taxes Payable
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Income Taxes Payable of -$1.78 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2025-11-12
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$22.62M.
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2016-12-31 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2015-12-31 was -$1.30M.
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2014-12-31 was -$5.88M.
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for fiscal 2016 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for fiscal 2015 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in income taxes payable for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$22.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.78M 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $20.84M 10-Q · filed 2025-08-13 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | |||
| 2015-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | ||
| 2015-09-30 | $1.30M 10-Q · filed 2016-11-09 | |||
| 2014-12-31 | -$5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $5.88M 10-Q · filed 2015-11-12 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |